eF-site ID 6g5f-ABP
PDB Code 6g5f
Chain A, B, P

click to enlarge
Title Crystal structure of an engineered Botulinum Neurotoxin type B mutant E1191M/S1199Y in complex with human synaptotagmin 1
Classification TOXIN
Compound Botulinum neurotoxin type B
Source (SYT1_HUMAN)
Sequence A:  PVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITD
RIWIIPERYTFGYKPEDFNKSSGIFNRDVCEYYDPDYLNT
NDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLGD
RRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIF
GPGPVLNENETIDIGIQNHFASREGFGGIMQMKFCPEYVS
VFNNVQENKGASIFNRRGYFSDPALILMHQLIYVLHGLYG
IKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIIT
PSTDKSIYDKVLQNFRGIVDRLNKVLVCISDPNININIYK
NKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETNI
AENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNIS
DKDMEKEYRGQNKAINKQAYEEISKEHLAVYKIQMCKSVK
B:  APGICIDVDNEDLFFIADKNSFSDDLSKNERIEYNTQSNY
IENDFPINELILDTDLISKIELPSENTESLTDFNVDVPVY
EKQPAIKKIFTDENTIFQYLYSQTFPLDIRDISLTSSFDD
ALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVNDF
VIEANKSNTMDKIADISLIVPYIGLALNVGNETAKGNFEN
AFEIAGASILLEFIPELLIPVVGAFLLESYIDNKNKIIKT
IDNALTKRNEKWSDMYGLIVAQWLSTVNTQFYTIKEGMYK
ALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLN
EGINQAIDNINNFINGCSVSYLMKKMIPLAVEKLLDFDNT
LKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDLS
IYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGY
GAKVEVYDGVELNDKNQFKLTSSANSKIRVTQNQNIINSV
FLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNSGW
KISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRW
FFVTITNNLNNAKIYINGKLESNTDIKDIREVIANGEIIF
KLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSYSE
YLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEIL
TRSKYNQNSKYINYRDLYIGEKFIIRRKSNSQSINDDIVR
KEDYIYLDFFNLNQEWRVYTYKYFKKEEMKLFLAPIYDSD
EFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHR
FYESGIYKDYFCISKWYLKEVKRKPYNLKLGCNWQFIPKD
EGWTE
P:  KEDAFSKLKEKFMNELHK
Description


Functional site

1) chain A
residue 69
type
sequence D
description binding site for residue GOL A 1301
source : AC1

2) chain A
residue 259
type
sequence Q
description binding site for residue GOL A 1301
source : AC1

3) chain A
residue 375
type
sequence S
description binding site for residue GOL A 1301
source : AC1

4) chain B
residue 452
type
sequence E
description binding site for residue GOL A 1301
source : AC1

5) chain A
residue 207
type
sequence Q
description binding site for residue GOL A 1302
source : AC2

6) chain A
residue 275
type
sequence Q
description binding site for residue GOL A 1302
source : AC2

7) chain B
residue 705
type
sequence L
description binding site for residue GOL A 1302
source : AC2

8) chain B
residue 709
type
sequence N
description binding site for residue GOL A 1302
source : AC2

9) chain A
residue 123
type
sequence R
description binding site for residue GOL A 1303
source : AC3

10) chain A
residue 124
type
sequence V
description binding site for residue GOL A 1303
source : AC3

11) chain A
residue 130
type
sequence N
description binding site for residue GOL A 1303
source : AC3

12) chain A
residue 259
type
sequence Q
description binding site for residue MLI B 1301
source : AC4

13) chain A
residue 374
type
sequence F
description binding site for residue MLI B 1301
source : AC4

14) chain A
residue 376
type
sequence D
description binding site for residue MLI B 1301
source : AC4

15) chain B
residue 452
type
sequence E
description binding site for residue MLI B 1301
source : AC4

16) chain B
residue 454
type
sequence L
description binding site for residue MLI B 1301
source : AC4

17) chain B
residue 456
type
sequence F
description binding site for residue MLI B 1301
source : AC4

18) chain B
residue 710
type
sequence T
description binding site for residue MLI B 1301
source : AC4

19) chain B
residue 713
type
sequence Y
description binding site for residue MLI B 1301
source : AC4

20) chain B
residue 714
type
sequence T
description binding site for residue MLI B 1301
source : AC4

21) chain A
residue 230
type catalytic
sequence H
description 626
source MCSA : MCSA1

22) chain A
residue 231
type catalytic
sequence Q
description 626
source MCSA : MCSA1

23) chain A
residue 234
type catalytic
sequence Y
description 626
source MCSA : MCSA1

24) chain A
residue 268
type catalytic
sequence E
description 626
source MCSA : MCSA1

25) chain A
residue 370
type catalytic
sequence R
description 626
source MCSA : MCSA1

26) chain A
residue 231
type ACT_SITE
sequence Q
description ACT_SITE => ECO:0000255|PROSITE-ProRule:PRU10095
source Swiss-Prot : SWS_FT_FI1

27) chain A
residue 268
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:10932256, ECO:0007744|PDB:1EPW, ECO:0007744|PDB:1F31, ECO:0007744|PDB:2NP0
source Swiss-Prot : SWS_FT_FI3

28) chain B
residue 1189
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:10932256, ECO:0000305|PubMed:14731268, ECO:0007744|PDB:4KBB
source Swiss-Prot : SWS_FT_FI5

29) chain B
residue 1240
type BINDING
sequence I
description BINDING => ECO:0000269|PubMed:10932256, ECO:0000305|PubMed:14731268, ECO:0007744|PDB:4KBB
source Swiss-Prot : SWS_FT_FI5

30) chain A
residue 230
type BINDING
sequence H
description BINDING => ECO:0000255|PROSITE-ProRule:PRU10095, ECO:0000269|PubMed:10932256, ECO:0000305|PubMed:1429690, ECO:0007744|PDB:1EPW, ECO:0007744|PDB:1F31, ECO:0007744|PDB:2NP0
source Swiss-Prot : SWS_FT_FI2

31) chain A
residue 234
type BINDING
sequence Y
description BINDING => ECO:0000255|PROSITE-ProRule:PRU10095, ECO:0000269|PubMed:10932256, ECO:0000305|PubMed:1429690, ECO:0007744|PDB:1EPW, ECO:0007744|PDB:1F31, ECO:0007744|PDB:2NP0
source Swiss-Prot : SWS_FT_FI2

32) chain B
residue 1025
type BINDING
sequence N
description BINDING => ECO:0007744|PDB:4KBB
source Swiss-Prot : SWS_FT_FI4


Display surface

Download
Links